Table 1.
Study | Countries | Data/Variable | Key Findings | Relevance |
---|---|---|---|---|
Baird, 2016 [1] | Australia, France, Israel, Japan, Poland, Russia, Slovenia, Switzerland, United States | Individual survey on OOP spending compared to income from Luxembourg Income Study (2010 for most countries) | • In median country, 13% of people spend more than 10% of income in OOP. • Varies from 3% (France) to 17% (Switzerland). • Poor and elderly at greatest risk of cata-strophic spending. |
• Focuses on percentage of population with high OOP spending during a single year. • Emphasizes groups that are most financially vulnerable. • Does not examine countries’ health policies. • Does not examine perceived barriers on access to care. |
Palladino et al., 2016 [2] | Austria, Belgium, Czech Republic, Denmark, France, Germany, Netherlands, Spain, Sweden, Switzerland | Survey of people age 50 and older from Health, Ageing and Retirement in Europe, with data on changes in OOP spending and experiencing catastrophic OOP spending (30% or more of income), from 2006/7 to 2013 (Great Recession) | • Very large range in changes in OOP spending (− 11% in Netherlands to + 101% in Austria). • Increase in catastrophic spending: from 2.3 to 3.9% over study period. • People age 50 and older spent more in 8 of11 countries. • Countries do provide financial protection for poor. |
• Focuses on changes in OOP spending during limited time period. • Does not examine countries’ health policies. • Does not examine perceived barriers on access to care. |
Tambor et al., 2011 [3] | 27 countries in the European Union | Review of international data bases, laws and regulations, and reports on changes in patient cost sharing requirements since 1990 | • Cost-sharing requirements vary a great deal between countries, and have increased significantly in many. • Tax-based systems more likely to use co-payments, insurance-based systems more likely to use deductibles and coinsurance. • Almost all countries have policies to protect the poorest and/or sickest. |
• Focuses on health policies in countries, but little detail provided. • Includes extremely diverse set of countries. • Does not examine perceived barriers on access to care. |
Zare & Anderson, 2013 [4] | France, Germany, Japan, United Kingdom, United States (Medicare only) | Various data sets from OECD, WHO, European Observatory, and country-specific reports, time period 2000–2010; separately examine cost sharing for pharmaceuticals, inpatient, and ambulatory care | • Inflation-adjusted OOP spending, and spending divided by income, increased in all countries. • Percent of total national health care paid OOP declined in most countries due to protection mechanisms for poor and/or sick. |
• Focuses on health policies in 5 countries. • Does not examine perceived barriers on access to care. |